GLI1 and neoplasm: In several tumors, including MB, the aberrant activation of Hh signaling contributes to CSCs proliferation by the Gli mediated regulation of stemness marker Nanog. 61, 62 The presence of CSCs in the tumor mass is a major cause of resistance and favors tumor relapse,63 thus representing an attractive druggable targets for anticancer therapy.